Redwood Park Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Redwood Park Advisors's BMY Position: Q4 2025 in Review
Redwood Park Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 274 shares — an estimated $12.3K sold.
Redwood Park Advisors first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $19K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Redwood Park Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Redwood Park Advisors sold 274 Bristol-Myers Squibb shares in Q4 2025, an estimated $12.3K.
- Redwood Park Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
- Redwood Park Advisors's Bristol-Myers Squibb position peaked at $19K in Q1 2025.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Redwood Park Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.